XM does not provide services to residents of the United States of America.
L
L

LaboratoryCorporation

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Labcorp Acquires Select Assets Of Lab Works

BRIEF-Labcorp Acquires Select Assets Of Lab Works Nov 20 (Reuters) - Labcorp Holdings Inc LH.N : LABCORP ACQUIRES SELECT ASSETS OF LAB WORKS Source text: [ID:] Further company coverage: LH.N
L

Cinven secures Italian nod to sell minority stake in Synlab to Labcorp

Cinven secures Italian nod to sell minority stake in Synlab to Labcorp ROME, Nov 20 (Reuters) - Private equity firm Cinven secured a conditional approval from Italian authorities over its plan to sell a 15% stake in diagnostic service provider Synlab to laboratory operator Labcorp LH.N , a government document sent to parliament showed. Golden powers legislation requires Italian government approval for any decision which results in changes in the ownership, control or availability of strategic as
L

U.S. Apellis Pharmaceuticals, Energizer Holdings, Walmart

U.S. RESEARCH ROUNDUP- Apellis Pharmaceuticals, Energizer Holdings, Walmart Nov 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apellis Pharmaceuticals, Energizer Holdings and Walmart, on Wednesday. HIGHLIGHTS * Apellis Pharmaceuticals Inc APLS.O : JP Morgan cuts target price to $50 from $57 * Chord Energy Corp CHRD.O : RBC cuts target price to $180 from $185 * Energizer Holdings Inc ENR.N : JP Morgan raises to ne
S
L

U.S. STOCKS Merck, Microstrategy, Illumina

U.S. STOCKS ON THE MOVE-Merck, Microstrategy, Illumina Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the tech-heavy Nasdaq edged higher on Tuesday, paring earlier losses as investors assessed Russia's warning to the United States with a new nuclear doctrine, and awaited quarterly results from AI-heavyweight Nvidia.
G
I
I
I
N
K
U
U
U
J
L

U.S. STOCKS Merck, Microstrategy Inc, Zepp Health Corp

BUZZ-U.S. STOCKS ON THE MOVE-Merck, Microstrategy Inc, Zepp Health Corp Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell on Tuesday, as escalating tensions between Russia and Ukraine dented risk appetite globally and sent investors rushing for safe-haven assets.
G
I
I
K
U
U
J
L

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.